Search details
1.
Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir.
Clin Infect Dis
; 78(3): 562-572, 2024 03 20.
Article
in English
| MEDLINE | ID: mdl-38036487
2.
Fosmanogepix Therapy of Disseminated Fusarium Infection.
Clin Infect Dis
; 77(6): 848-850, 2023 09 18.
Article
in English
| MEDLINE | ID: mdl-37220752
3.
Unexpected Cytomegalovirus (CMV) Replication Kinetics in CMV Donor-Seropositive, Recipient-Seronegative Liver Transplant Recipients Receiving Preemptive Antiviral Therapy.
J Infect Dis
; 225(3): 436-442, 2022 02 01.
Article
in English
| MEDLINE | ID: mdl-33755176
4.
Risk Factors for Cytomegalovirus Viremia following Liver Transplantation With a Seropositive Donor and Seronegative Recipient Receiving Antiviral Therapy.
J Infect Dis
; 223(6): 1073-1077, 2021 03 29.
Article
in English
| MEDLINE | ID: mdl-32726431
5.
Cost-effectiveness of Preemptive Therapy Versus Prophylaxis in a Randomized Clinical Trial for the Prevention of Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors.
Clin Infect Dis
; 73(9): e2739-e2745, 2021 11 02.
Article
in English
| MEDLINE | ID: mdl-32712663
6.
Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT Study.
Clin Infect Dis
; 71(9): 2365-2374, 2020 12 03.
Article
in English
| MEDLINE | ID: mdl-32076709
7.
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients.
Clin Infect Dis
; 71(11): 2777-2786, 2020 12 31.
Article
in English
| MEDLINE | ID: mdl-31793991
8.
Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors: A Randomized Clinical Trial.
JAMA
; 323(14): 1378-1387, 2020 04 14.
Article
in English
| MEDLINE | ID: mdl-32286644
9.
Good Outcomes in Therapy of Fusariosis Depend on Both an Effective Drug and the Host.
Clin Infect Dis
; 2024 Jan 04.
Article
in English
| MEDLINE | ID: mdl-38174352
10.
A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile-associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation.
Clin Infect Dis
; 68(2): 196-203, 2019 01 07.
Article
in English
| MEDLINE | ID: mdl-29893798
11.
12.
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(2): 369-381, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30292744
13.
Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial.
Lancet
; 391(10135): 2116-2127, 2018 05 26.
Article
in English
| MEDLINE | ID: mdl-29856344
14.
Increased Incidence of Nocardial Infections in an Era of Atovaquone Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
Biol Blood Marrow Transplant
; 24(8): 1715-1720, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29555315
15.
CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation.
N Engl J Med
; 369(13): 1227-36, 2013 Sep 26.
Article
in English
| MEDLINE | ID: mdl-24066743
16.
Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults.
J Infect Dis
; 208(9): 1375-85, 2013 Nov 01.
Article
in English
| MEDLINE | ID: mdl-23908479
17.
Response.
Biol Blood Marrow Transplant
; 24(9): 1953-1954, 2018 09.
Article
in English
| MEDLINE | ID: mdl-29909155
18.
Transient SARS-CoV-2 RNA-Dependent RNA Polymerase Mutations after Remdesivir Treatment for Chronic COVID-19 in Two Transplant Recipients: Case Report and Intra-Host Viral Genomic Investigation.
Microorganisms
; 11(8)2023 Aug 16.
Article
in English
| MEDLINE | ID: mdl-37630656
19.
Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant.
Open Forum Infect Dis
; 10(8): ofad386, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37636519
20.
Efficacy, safety, and breakthrough infections associated with standard long-term posaconazole antifungal prophylaxis in allogeneic stem cell transplantation recipients.
Biol Blood Marrow Transplant
; 17(4): 507-15, 2011 Apr.
Article
in English
| MEDLINE | ID: mdl-20460163